Publication | Closed Access

Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting

InfertilityUrologyFertilityReproductive HealthGynecologyFemale Reproductive SystemClinical OutcomesFinal Oocyte MaturationReproductive HormoneHuman ReproductionHormone AgonistEndocrinologyMedicinePublic HealthOvarian HormoneWomen's HealthOvarian Cancer